RUDY LOZANO CARREON: Open Payments
NPI 1104388941 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$360 in 16 payments from 9 companies in 2025. Trend: 2023 $50 · 2024 $301 · 2025 $360
Food & beverage: $360
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $82 |
| Otsuka America Pharmaceutical, Inc. | 4 | $67 |
| Tempus AI, Inc | 2 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Neos Therapeutics, LP | 2 | $35 |
| Biogen, Inc. | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Tris Pharma Inc | 1 | $21 |
| Lundbeck LLC | 1 | $17 |
Products named: REXULTI, Auvelity, TEMPUS PIXEL, TRINTELLIX, Adzenys XR-ODT, ZURZUVAE, CAPLYTA, Dyanavel XR.
Industry payments across TX — which companies pay providers there.
